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ABSTRACT
Background: Endoscopic tri-modal imaging (ETMI)
incorporates white light endoscopy (WLE), autofluores-
cence imaging (AFI) and narrow-band imaging (NBI).
Aims: To assess the value of ETMI for the detection and
classification of neoplasia in patients with longstanding
ulcerative colitis.
Design: Randomised comparative trial of tandem
colonoscopies.
Setting: Academic Medical Centre Amsterdam,
Netherlands.
Patients and methods: Fifty patients with ulcerative
colitis underwent surveillance colonoscopy with ETMI.
Each colonic segment was inspected twice, once with AFI
and once with WLE, in random order. All detected lesions
were inspected by NBI for Kudo pit pattern analysis and
additional random biopsies were taken.
Main outcome measures: Neoplasia miss-rates of AFI
and WLE, and accuracy of the Kudo classification by NBI.
Results: Among patients assigned to inspection with AFI
first (n=25), 10 neoplastic lesions were primarily
detected. Subsequent WLE detected no additional
neoplasia. Among patients examined with WLE first
(n=25), three neoplastic lesions were detected;
subsequent inspection with AFI added three neoplastic
lesions. Neoplasia miss-rates for AFI and WLE were 0%
and 50% (p=0.036). The Kudo classification by NBI had
a sensitivity and specificity of 75% and 81%; however, all
neoplasia was coloured purple on AFI (sensitivity 100%).
No additional patients with neoplasia were detected by
random biopsies.
Conclusion: Autofluorescence imaging improves the
detection of neoplasia in patients with ulcerative colitis
and decreases the yield of random biopsies. Pit pattern
analysis by NBI has a moderate accuracy for the
prediction of histology, whereas AFI colour appears
valuable in excluding the presence of neoplasia.
Trial registration number: ISRCTN05272746
Patients with longstanding ulcerative colitis are at
increased risk of developing colorectal cancer.
12
Since colonoscopic surveillance in ulcerative colitis
patients appears to lead to early detection and
improved prognosis of neoplasia, guidelines recom-
mend surveillance for these patients.
3–6 However,
neoplasia mainly develops in flat mucosa, so it can
easily be overlooked during colonoscopy.
7–10
Therefore, random biopsies are recommended in
addition to targeted biopsies of suspicious lesions.
4–6
Despite these great efforts, neoplasia is still fre-
quently being missed by colonoscopy, possibly
leading to interval cancers.
11 12
New endoscopic imaging techniques aim to
facilitate the detection of neoplasia.
13
Chromoendoscopy (CE) has been proven to
increase the detection of neoplasia in ulcerative
colitis and, additionally, enables pit pattern analy-
sis for an accurate endoscopic classification by
experts.
14–17 Nevertheless, implementation of CE in
clinical practice has fallen short since it is labour-
intensive and requires special training. By contrast,
narrow-band imaging (NBI) utilises spectral char-
acteristics of endoscopic light to enhance mucosal
details without dyes.
18–20 Recently, NBI failed to
improve the detection of neoplasia in ulcerative
colitis,
11 yet has been judged a valuable tool for
classification.
21 22 Whereas the diagnostic accuracy
of NBI for differentiation of neoplastic and non-
neoplastic tissue in ulcerative colitis remains to be
clarified, its accuracy for differentiating sporadic
polyps has shown to be comparable to CE.
23–27
Autofluorescence imaging (AFI) is another novel
technique, using short-wavelength (blue) light for
excitation of endogenous tissue fluorophores
which emit fluorescent light of longer wave-
length.
28 Therefore, AFI highlights neoplastic tissue
without administration of exogenous fluorophores
as described before in ulcerative colitis patients.
29 30
Recently, high-resolution white-light endoscopy
(WLE), AFI and NBI have been incorporated into
one system: endoscopic tri-modal imaging
(ETMI).
31 To date, ETMI has only been evaluated
in patients with Barrett’s oesophagus and AFI has
only been described in two patients with ulcerative
colitis.
32 33 The aims of this randomised study were
to compare AFI and WLE for the detection of
neoplasia in patients with longstanding ulcerative
colitis, and to assess the accuracy of NBI for pit
pattern classification.
PATIENTS AND METHODS
Participants
Patients with inactive pan-ulcerative colitis
>8 years scheduled for surveillance colonoscopy
at the Academic Medical Centre Amsterdam were
invited for this study. A modified Truelove & Witts
severity index (2 was used to define inactive
Ulcerative colitis
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34 Exclusion criteria were insufficient bowel preparation,
endoscopically active inflammation, age (18 years, non-cor-
rectable coagulopathy, and inability to give informed consent.
Endoscopy equipment
All colonoscopies were performed with a prototype ETMI
system (Olympus Inc., Tokyo, Japan). The light source (XCLV-
260HP) contains two rotating red–green–blue RGB filters; one
conventional for WLE and one additional for NBI, in which the
band-pass ranges are narrowed to wavelengths of 530–550 nm
(green) and 390–445 nm (blue). For NBI, the relative intensity
of blue light is increased. Since blue light penetrates the mucosa
only superficially and is the main colour absorbed by
haemoglobin, this setting enhances surface and capillary details
(fig 1A–D).
18 19
The zoom video-colonoscope (XCF-H240FZL; magnification
6100) contains two charge-coupled devices, one for WLE/NBI
and one for AFI. In the AFI mode, blue light (390–470 nm) is
used for excitation and green light (540–560 nm) for reflection.
A barrier filter is used to detect autofluorescence and reflected
light with wavelengths of 500–630 nm only. The sequentially
detected images of autofluorescence and green reflection are
integrated by the processor into a real-time pseudo-colour
image. During AFI normal mucosa appears green, while
neoplasia appears purple (fig 1A,D).
A high-resolution monitor was usedfor all procedures,inwhich
the endoscopist could easily switch between the three imaging
modes by pressing a button on the shaft of the endoscope.
Colonoscopic procedure and randomisation
Patients were prepared with 4 litres of hypertonic polyethylene
glycol solution (Kleanprep; Norgine, Marburg, Germany) and
received conscious sedation. The endoscope was advanced in the
WLE mode and caecal intubation was confirmed by identifica-
tion of the appendiceal orifice and ileocaecal valve. No biopsies
were taken during insertion of the endoscope. All procedures
were performed by three experienced colonoscopists (.2500
colonoscopies).
Upon reaching the caecum, the level of bowel preparation
was determined: good (100% visible mucosa), moderate (90–
100%) or poor (,90%). On introduction of the endoscope
efforts were made to optimally clean the bowel by rinsing and
suctioning. Poor bowel preparation was an exclusion criterion,
as well as endoscopically active disease in at least one colonic
segment.
During withdrawal of the colonoscope, each colonic segment
was inspected twice: once with AFI and once with WLE. The
hepatic and splenic flexures separated the colonic segments; in
case of indistinct flexures a biopsy was taken for reference
during the second inspection. Patients were randomly allocated
for inspection with AFI or WLE first in all segments (fig 2). One
hundred opaque sealed envelopes contained notes with ‘‘AFI’’ or
‘‘WLE’’ written on them (1:1) for randomisation. At the
moment of caecal intubation, a research fellow opened a
randomly chosen envelope for allocation. The endoscopists
were instructed to have equal inspection times for AFI and WLE.
In a random sample of 10 patients inspection times were
measured for both AFI and WLE, strictly excluding time for
rinsing, taking pictures and taking biopsies. Suspicious lesions
detected during the first inspection were sampled immediately
after detection. During the second inspection, only additionally
detected suspicious lesions were sampled. Finally, four quadrant
random biopsies were taken every 10 cm of colon. For each
lesion, the detection technique (WLE or AFI), size (estimated by
Figure 1 ( A )I m a g e sd u r i n gh i g h -
resolution white-light endoscopy (WLE) (a);
autofluorescence imaging (AFI) (b);
and narrow-band imaging (NBI) (c), of
mucosa with (d) no significant changes
on histology. On AFI normal mucosa
appears green; NBI shows a normal pit
pattern (Kudo type I). (B). Images during
WLE (a), AFI (b), and NBI (c), of a lesion
revealing hyperplastic-like mucosal
changes on histopathology (d). Tissue
autofluorescence is disturbed leading to
a purple (false positive) colour on AFI;
during NBI a normal pit pattern is seen.
(C) Images during WLE (a), AFI (b), and
NBI (c), of an area showing inflammation
on histopathology (d). On AFI,
inflammation becomes purple (false
positive), drawing the attention of the
endoscopist. On NBI, an irregular pit
pattern is seen, partly with elongated
pits (Kudo type IIIL). (D) Images during
WLE (a), AFI (b), and NBI (c), of a mass
revealing low-grade intraepithelial
neoplasia on histopathology (d). The
neoplastic lesion appears deep purple on
AFI and reveals Kudo pit pattern type IV
on NBI.
Ulcerative colitis
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and distance from the anus) were noted.
35 Furthermore, AFI
colour (green, ambiguous or purple) was scored as well as the
Kudo classification by NBI and magnification.
36
During inspection with WLE, suspicious lesions were defined
as polypoid or irregular mucosal structures, unusual ulcers and
strictures. During AFI, all areas with ambiguous/purple colour
were considered suspicious.
Histopathological diagnosis
Biopsies were evaluated by two blinded pathologists, one of them
considered a gastrointestinal expert. Biopsies were classified
according to the Vienna criteria of gastrointestinal epithelial
neoplasia.
37 In the case of discrepancy between the pathologists,
discussion led to a consensus diagnosis. Low-grade (LGIN) and
high-grade intraepithelial neoplasia (HGIN), as well as invasive
neoplasia were defined as neoplasia; lesions diagnosed as
indefinite for neoplasia were not considered neoplastic.
A significant number of biopsies showed hypermucinous,
serrated, epithelial changes reminiscent of hyperplastic polyps,
which could not be recognised as overt intraepithelial neoplasia
and of which the significance is unknown. These lesions appear
similar to the lesions described by Kilgore et al
38 in Crohn’s
disease as hyperplastic-like mucosal changes (HPC). The
presence of these lesions was recorded separately and the term
‘‘HPC’’ was adopted from the study by Kilgore et al.
Primary and secondary outcomes
The primary outcomes were the proportions of neoplastic
lesions missed by AFI or WLE, and the accuracy of the Kudo
classification assessed by NBI. Secondary outcomes were
proportions of patients with missed neoplasia, patients with
neoplasia detected by random biopsies only, number of false
positive lesions and the accuracy of AFI colour.
Statistical methods
Continuous data were represented by their mean¡standard
deviation (SD) or by their median¡interquartile range (IQR)
when appropriate. Differences were tested by the Student t test
or Wilcoxon rank test, respectively. Proportions were compared
by the x
2 or Fisher’s exact test.
Since lesions were sampled immediately after detection, only
missed lesions could be detected by the second technique, which
precludes a paired analysis. In order to compare AFI and WLE
for neoplasia detection, we therefore compared the number of
neoplastic lesions detected by the second inspection divided by
the total number of detected neoplastic lesions (first and second
inspection), representing the miss-rate for each technique.
These proportions were compared using Fisher’s exact test.
The proportions of patients with missed neoplasia were
compared in the same manner.
Contingency tables were used to determine sensitivity,
specificity and overall accuracy (95% confidence intervals) of
the Kudo classification by NBI and of the AFI colour.
Histopathology was used as the ‘‘gold standard’’.
The number of false positive lesions during AFI and WLE
(suspicious lesion on endoscopy but negative for neoplasia on
histology) was compared using the paired Wilcoxon rank test.
Sample size
When previously applying identical inclusion criteria, the
neoplasia prevalence was 29% and the neoplasia miss-rate for
WLE was 54% (per lesion analysis).
11 We assumed the neoplasia
miss-rate for AFI to be 10% and expected patients with
Figure 2 Study design and flow chart of
patients who gave informed consent
during the study. The number of detected
neoplastic lesions and number of patients
with neoplasia are summarised per
randomisation group. During white-light
endoscopy (WLE), three neoplastic
lesions (50%) were missed which were
detected by autofluorescence imaging
(AFI). Two random biopsies showed
neoplasia after inspection with AFI and
subsequent WLE; these were found in a
patient in whom AFI already detected
three areas of flat neoplasia.
Ulcerative colitis
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sample size of 50 patients (a-error 0.05 and b-error 0.2).
RESULTS
Patient characteristics
From April 2005 to November 2006 a total of 58 patients gave
informed consent. Eight patients were excluded because of poor
bowel preparation (n=3) or endoscopically active disease
(n=5). Therefore, 50 patients were randomised for tandem
colonoscopy; in 25 patients the first inspection was done with
AFI, in the other 25 patients WLE was used first (fig 2). Baseline
characteristics are summarised according to randomisation in
table 1. The three endoscopists performed 18, 18 and 14
procedures each and no complications occurred in any of the
patients.
Duration of colonoscopy and number of suspicious lesions
The mean inspection time for AFI was 8.1 (SD 2.7) min and for
WLE 7.9 (SD 3.9) min (p=0.757). During examination with
AFI first, 37 suspicious lesions were detected (16 patients);
second inspection with WLE added seven lesions (seven
patients). Inspection with WLE first yielded 34 suspicious
lesions (18 patients) and subsequent AFI added 20 lesions (11
patients).
Neoplasia in targeted biopsies
Autofluorescence imaging first
Among the 25 patients assigned to inspection with AFI first, 10
neoplastic lesions were detected with AFI (six patients).
Subsequent examination with WLE detected no additional
neoplasia (fig 2). No lesions indefinite for neoplasia were found
in this group.
The first patient had three flat elevated lesions of 4–10 cm
throughout the colon, all harbouring LGIN; subsequent
colectomy demonstrated LGIN and focal HGIN at the same
colonic sites as during colonoscopy. The second patient also had
three flat elevated lesions, all 4 mm in size revealing LGIN.
Given the small size, these lesions were considered as adenoma-
like masses (ALMs) and removed by endoscopic mucosal
resection; repeat colonoscopy within 1 year again revealed
LGIN. Three other patients harboured one flat lesion each (of
3, 5 and 17 mm) with LGIN, which were considered as ALMs
although one of these patients had three areas of flat LGIN
detected within 1 year. The last patient harboured a 10 cm
irregular area with focal HGIN which had already been noticed
on introduction of the endoscope. This patient underwent
colectomy in which no neoplasia could be demonstrated; after
reviewing the original biopsies there was no doubt about the
initial diagnosis of HGIN.
White-light endoscopy first
Among 25 patients assigned to WLE first, three neoplastic
lesions were detected with WLE (two patients). Subsequent
inspection with AFI added three neoplastic lesions (two
patients). No lesions indefinite for neoplasia were found.
The first patient with WLE detected neoplasia had a 6 mm
flat elevated lesion with LGIN, considered as ALM. The second
patient harboured a 6 cm nodular flat lesion in the caecum and
a 1 cm polypoid lesion in the descending colon, both revealing
LGIN. Total colectomy in that patient only confirmed LGIN in
the caecum. All neoplastic lesions detected by WLE were
coloured purple on AFI. White-light endoscopy failed to detect
three lesions with LGIN in two patients, which were detected
by AFI during the second inspection. In one patient, two sessile
lesions of 3 mm were missed in the sigmoid colon revealing
LGIN; in the other patient a sessile lesion of 5 mm was missed
revealing LGIN. Repeat colonoscopy within 1 year again
revealed LGIN at other areas in both patients with missed
neoplasia.
Of the 10 patients with neoplasia, three were referred to our
hospital to confirm the presence of neoplasia, three had a
history of ALM resection at our own institution and one had
previous neoplasia in random biopsies. Only one patient with
neoplasia had a history of primary sclerosing cholangitis (PSC).
There were no differences in neoplasia detection between
endoscopists or between early or late ETMI procedures.
Neoplasia in random biopsies
In total, 1992 random biopsies were taken among 50 patients. In
two biopsies (0.1%) histopathology revealed LGIN, both taken
in a patient in whom AFI already demonstrated three neoplastic
lesions, confirmed by colectomy. The first positive random
biopsy was taken in an AFI purple region of which targeted
biopsies revealed inflammation on histology; the second was
taken just proximal to a neoplasia detected by AFI.
Furthermore, eight random biopsies showed mucosal changes
indefinite for neoplasia (four patients), 252 inflammation, 100
HPC and 1632 showed no significant changes.
Two of the four patients with indefinite neoplasia in random
biopsies underwent colectomy for neoplasia in targeted biopsies
as well; in the remaining two patients with indefinite neoplasia,
three subsequent follow-up colonoscopies did not reveal any
neoplasia.
Neoplasia miss-rates
The percentage of missed neoplastic lesions was 0% (0/10) for
AFI and 50% (3/6) for WLE (p=0.036). The percentage of
patients with neoplasia missed by AFI was 0% (0/6) vs 50%
(2/4) for WLE (p=0.133).
Table 1 Baseline patient characteristics among patients randomly assigned to autofluorescence imaging
(AFI) and white-light endoscopy (WLE) as the first examination technique
Characteristic
Randomisation
p Value AFI first (n=25) WLE first (n=25)
Male, n (%) 17 (68%) 14 (56%) 0.382
Mean age, years (SD) 50 (11) 51 (13) 0.889
Duration of median ulcerative colitis, years (IQR) 16 (12–21) 14 (12–20) 0.651
History of neoplasia, n (%) 3 (12%) 4 (16%) 1.0
Primary sclerosing cholangitis, n (%) 3 (12%) 4 (16%) 1.0
Disease-modifying drug use, n (%) 23 (92%) 18 (72%) 0.138
Good colon preparation, n (%) 14 (56%) 20 (80%) 0.069
Ulcerative colitis
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(n=2), corresponding neoplasia miss-rates for AFI and WLE
were 17% (2/12) and 50% (3/6) respectively (p=0.268).
False positive findings
During inspection with AFI, a total of 44 false positive lesions
were found compared to 38 during WLE (p=0.882). Of all false
positive lesions by AFI, histology showed inflammation in 22
lesions (50%) and HPC in two (4.5%). Histology of false positive
lesions by WLE showed inflammation in six lesions (16%) and
HPC in 13 (34%). All other false positive lesions showed no
significant changes on histology.
Findings on narrow-band imaging and autofluorescence imaging
compared to histology
Fifty-seven suspicious lesions were found with AFI and 41 with
WLE, which were all inspected by NBI before taking biopsies. Of
the 16 histologically proven neoplastic lesions, four showed
non-neoplastic pit patterns (type I–II) on NBI; of the 82
remaining non-neoplastic lesions, 16 demonstrated neoplastic
pit patterns (type III–V) due to chronic inflammation. The
sensitivity, specificity and overall accuracy of the Kudo
classification by NBI were 75% (95% CI, 51 to 90), 81% (71 to
88) and 80% (71 to 86) respectively (table 2).
All suspicious lesions were also scored for colour on AFI.
Considering AFI green as non-neoplastic and AFI purple/
ambiguous as neoplastic the sensitivity, specificity and overall
accuracy of AFI colour were 100% (81 to 100), 42% (31 to 52)
and 51% (41 to 61), respectively.
When combining AFI and NBI findings, thereby considering
AFI green as well as all AFI-ambiguous lesions with Kudo type
I–II on NBI as negative for neoplasia, the sensitivity, specificity
and overall accuracy were 100% (81 to 100), 72% (61 to 81) and
77% (67 to 84). This combined use of AFI plus NBI could
hypothetically have prevented taking targeted biopsies of 59
lesions (60%) without leaving neoplasia in situ.
DISCUSSION
This is the first randomised study comparing AFI to WLE for
detection and NBI for classification of neoplasia in patients with
longstanding ulcerative colitis. We have demonstrated that ETMI
is feasible for colonic use, provided that the colon is properly
prepared and not actively inflamed. Insufficient bowel prepara-
tion and active inflammation interrupt tissue autofluorescence,
resulting in discoloration on AFI and resembling neoplasia.
39–42
Active inflammation is an exclusion criterion for surveillance in
any ulcerative colitis patient, since histopathological distinction
between inflammation and neoplasia can be extremely difficult or
even impossible in this situation.
43 44 Disrupted autofluorescence
due to residual faeces may explain why patients allocated to AFI
inspection first were less often judged to have good colon
preparation as shown in table 1 (p=0.069). However, insufficient
bowel preparation does not uniquely preclude scrutinising the
colon duringAFI,but thisistruefor WLEaswell. Whenbecoming
accustomed to AFI during the study period, the percentage colon
preparation judged as good increased from 22% to 75% (early v
late procedures; p=0.017) among patients allocated to AFI first.
The present study demonstrated a neoplasia miss-rate of 50%
for WLE compared to a miss-rate of 0% for AFI (p=0.036).
Although all missed neoplastic lesions were considered ALMs
and have been treated by endoscopic mucosal resection, repeat
colonoscopy within 1 year confirmed the presence of neoplasia
in these patients. Debate still exists about whether ALMs
should prompt colectomy or can safely be removed by
endoscopic resection.
45 An important consideration is whether
ALMs are located within or proximal to the extent of inflamed
colon. All included patients had pancolitis and therefore hold a
higher risk for cancer development, even if neoplasia was
considered as an ALM. Since only intraepithelial neoplasias have
been found in our study, the value of AFI for the detection of
early invasive cancers could not be evaluated.
We found a high prevalence of neoplasia in our study
population, probably caused by the tertiary referral function
of our institution, selection of patients with pancolitis, and
inclusion of patients with a history of neoplasia without
colectomy. This high prevalence at our institution has been
demonstrated before in a study comparing standard WLE and
NBI, revealing a neoplasia miss-rate of 42% for WLE.
11 The even
higher miss-rate for high resolution WLE in the present study
suggests that AFI may correctly visualise a significant part of
neoplasia, which remains invisible for WLE. Despite appropriate
powering of the present study, however, the relatively small
sample size prompts confirmation of these results in larger
trials.
In a retrospective study, standard colonoscopy missed 39% of
all neoplasia which was only detected by additional random
biopsies.
10 The authors included neoplasia detected by random
biopsies in the denominator for measuring sensitivity and no
additional imaging techniques were used, as opposed to our
study. The neoplasia miss-rate for high resolution WLE in our
study was 50%, only missing lesions that were subsequently
visualised by AFI. Random biopsies did not add neoplasia in any
of these cases. Among patients examined with AFI first and
WLE second, two random biopsies revealed neoplasia, which
may be analysed as neoplasia missed by both AFI and WLE.
When including positive random biopsies, the neoplasia miss-
rate of AFI was 17% (2/12), which is still lower than current
practice. Two remarks must be made concerning those random
biopsies revealing ‘‘invisible’’ neoplasia. First, the positive
biopsies were both derived from one patient in whom AFI
already demonstrated three ‘‘visible’’ neoplastic lesions. Second,
one out of two biopsies was taken in an AFI purple region and
one was taken adjacent to a neoplasia visualised by AFI. The
presence of neoplasia in biopsies taken adjacent to visible
neoplasia merely reflects the nature of dysplasia associated
lesions or masses instead of missed neoplasia.
46 Therefore, we
conclude that random biopsies did not add relevant neoplasia.
The need for random biopsies in addition to the use of
advanced imaging techniques has been questioned several
times.
11 15 47 Random biopsies have a low yield of neoplasia
Table 2 Correspondence between the Kudo pit pattern classification
(by narrow-band imaging (NBI)) and histopathology (the gold standard)
of all detected lesions
NBI classification
Histopathology
Total Neoplastic
Non-
neoplastic
Suspicious 12 16 28,
PPV 43%
Non-suspicious 4 66 70,
NPV 94%
Total 16,
sens. 75%
82,
spec. 81%
98
Kudo pit pattern type I–II was considered as non-suspicious and Kudo type III–V as
suspicious for neoplasia.
NPV, negative predictive value; PPV, positive predictive value; sens., sensitivity; spec.,
specificity.
Ulcerative colitis
Gut 2008;57:1083–1089. doi:10.1136/gut.2007.144097 1087when used next to CE.
16 Also, in the present study the
diagnostic yield of random biopsies was low, only finding
neoplasia in 0.1% of biopsies. Random biopsies increase
examination time and pathology costs, may distract the
endoscopist from scrutinising the colon and have a risk of
bleeding. The fact that all neoplasia in this study was coloured
purple on AFI and that random biopsies did not detect neoplasia
in additional patients, underlines the question whether these
biopsies should be taken if AFI reveals a colon with the normal
‘‘green’’ appearance.
The high yield of neoplasia with AFI must be weighed against
the results of CE in previous studies.
14–17 In our experience, the
use of AFI is easier and more convenient for both patients and
endoscopists. Only pressing a button instead of applying dyes to
the mucosa will provide enhanced imaging, thereby saving time.
We experienced AFI to have a lower resolution compared to
high-resolution WLE, although it served well as a red flag
technique. The need for high resolution might be questioned in
the circumstance where AFI correctly visualised all neoplasia by
colouring purple. The results of the present study support the
use of AFI, but the small sample size and expert setting prompt
larger trials comparing AFI and CE in general practice to provide
practical recommendations.
Although AFI has demonstrated a high rate of false positive
findings in Barrett’s oesophagus, the present study showed that
there was no difference in false positive rate among AFI or WLE
in ulcerative colitis surveillance.
32 41 48 As known from previous
research, active inflammation colours purple during AFI.
42 The
present study demonstrated purple coloration of chronic
inflammation as well, which was the main cause of false
positive finding for AFI, whereas hyperplastic-like mucosal
change (HPC) was the most notable false positive finding for
WLE. These HPCs might be similar to the lesions described
before in Crohn’s disease, in which an association was shown
between the prevalence of HPC and concomitant neoplasia.
38
We could not demonstrate a correlation between HPC and
neoplasia in our study (results not shown), although prospec-
tive evaluation and molecular analysis of these lesions might be
an interesting subject for future studies.
Confocal endomicroscopy has recently proven to be a good
candidate to reduce false positive biopsies and to increase the
effectiveness of surveillance, although this technique requires
expensive equipment and special training.
15 49 In the present
study the Kudo classification with NBI had an unsatisfactory
specificity and sensitivity of 81% and 75%, figures which are
comparable to a recent report on pit pattern analysis with CE.
49
On the contrary, all neoplasias were coloured purple on AFI.
Therefore, the sensitivity of NBI could be improved by adding
the information about AFI colour in the rule for defining a
positive test result. All AFI green lesions and all AFI ambiguous
lesions with Kudo type I–II on NBI revealed non-neoplastic
histology, suggesting that those lesions can safely be left in situ.
Prospective studies should validate this finding, which might
lead to a sensitivity of 100% and specificity of 77%.
Instead of Kudo pit pattern analysis with NBI, the vascular
intensity pattern has also been used for differentiation of lesions
in the non-inflamed colon.
24–26 In a recent study by East et al
27
the accuracy of the Kudo classification was comparable to the
vascular intensity pattern in the non-inflamed colon. However,
the value of vascular pattern analysis in patients with ulcerative
colitis is still unknown.
In summary, ETMI appears a feasible option for colonoscopic
surveillance of patients with ulcerative colitis, although addi-
tional studies are imperative. In the present trial AFI reduced
the neoplasia miss-rate to 0% and made random biopsies
superfluous. For the endoscopic classification of lesions, NBI had
a sensitivity of only 75% but the additional information about
colour obtained by AFI increased the sensitivity to 100%. Larger
studies in a non-expert setting are needed to confirm these
results, as well as comparative trials with chromoendoscopy and
confocal endomicroscopy in order to demonstrate which
technique performs better and is more convenient for the
detection and classification of neoplasia.
Acknowledgements: The ETMI prototype endoscopy equipment was provided by
Olympus, Tokyo, Japan.
Funding: FJC van den Broek is supported by an unrestricted educational grant from
Olympus, Hamburg, Germany.
Competing interests: None.
Ethics approval: The study was approved by the medical ethical committee of our
institution on 16 February 2005.
REFERENCES
1. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with
inflammatory bowel diseases. Gastroenterology 2004;126:1634–48.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative
colitis: a meta-analysis. Gut 2001;48:526–35.
3. Collins P, Mpofu C, Watson A, et al. Strategies for detecting colon cancer and/or
dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev
2006;(2):CD000279.
4. Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and
surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314–21.
5. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic
colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51(Suppl
5):V10–V12.
6. Labianca R, Beretta GD, Mosconi S, et al. Colorectal cancer: screening. Ann Oncol
2005;16(Suppl 2):ii127–ii132.
7. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer. Problems in
assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum
1985;28:383–8.
8. Tytgat GN, Dhir V, Gopinath N. Endoscopic appearance of dysplasia and cancer in
inflammatory bowel disease. Eur J Cancer 1995;31A:1174–7.
9. Rutter M, Bernstein C, Matsumoto T, et al. Endoscopic appearance of dysplasia in
ulcerative colitis and the role of staining. Endoscopy 2004;36:1109–14.
10. Rubin DT, Rothe JA, Hetzel JT, et al. Are dysplasia and colorectal cancer
endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc
2007;65:998–1004.
11. Dekker E, van den Broek FJ, Reitsma JB, et al. Narrow-band imaging compared with
conventional colonoscopy for the detection of dysplasia in patients with longstanding
ulcerative colitis. Endoscopy 2007;39:216–21.
12. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic
surveillance program for neoplasia in ulcerative colitis. Gastroenterology
2006;130:1030–8.
13. Dekker E, Fockens P. New imaging techniques at colonoscopy: tissue spectroscopy
and narrow band imaging. Gastrointest Endosc Clin N Am 2005;15:703–14.
14. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy
for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.
Gastroenterology 2003;124:880–8.
15. Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy
increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis.
Gastroenterology 2007;132:874–82.
16. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying
for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256–60.
17. Hurlstone DP, Sanders DS, Lobo AJ, et al. Indigo carmine-assisted high-
magnification chromoscopic colonoscopy for the detection and characterisation of
intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy
2005;37:1186–92.
18. Gono K, Obi T, Yamaguchi M, et al. Appearance of enhanced tissue features in
narrow-band endoscopic imaging. J Biomed Opt 2004;9:568–77.
19. Kuznetsov K, Lambert R, Rey JF. Narrow-band imaging: potential and limitations.
Endoscopy 2006;38:76–81.
20. Gheorghe C. Narrow-band imaging endoscopy for diagnosis of malignant and
premalignant gastrointestinal lesions. J Gastrointestin Liver Dis 2006;15:77–82.
21. East JE, Suzuki N, von HA, et al. Narrow band imaging with magnification for
dysplasia detection and pit pattern assessment in ulcerative colitis surveillance: a
case with multiple dysplasia associated lesions or masses. Gut 2006;55:1432–5.
22. Matsumoto T, Kudo T, Jo Y, et al. Magnifying colonoscopy with narrow band
imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study.
Gastrointest Endosc 2007;66:957–65.
23. Machida H, Sano Y, Hamamoto Y, et al. Narrow-band imaging in the diagnosis of
colorectal mucosal lesions: a pilot study. Endoscopy 2004;36:1094–8.
Ulcerative colitis
1088 Gut 2008;57:1083–1089. doi:10.1136/gut.2007.14409724. Su MY, Hsu CM, Ho YP, et al. Comparative study of conventional colonoscopy,
chromoendoscopy, and narrow-band imaging systems in differential diagnosis of
neoplastic and nonneoplastic colonic polyps. Am J Gastroenterol 2006;101:2711–6.
25. Chiu HM, Chang CY, Chen CC, et al. A prospective comparative study of narrow-
band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of
colorectal neoplasia. Gut 2006;56:373–9.
26. Hirata M, Tanaka S, Oka S, et al. Magnifying endoscopy with narrow band imaging
for diagnosis of colorectal tumors. Gastrointest Endosc 2007;65:988–95.
27. East JE, Suzuki N, Saunders BP. Comparison of magnified pit pattern interpretation
with narrow band imaging versus chromoendoscopy for diminutive colonic polyps: a
pilot study. Gastrointest Endosc 2007;66:310–6.
28. DaCosta RS, Wilson BC, Marcon NE. Optical techniques for the endoscopic
detection of dysplastic colonic lesions. Curr Opin Gastroenterol 2005;21:70–9.
29. Messmann H, Endlicher E, Freunek G, et al. Fluorescence endoscopy for the
detection of low and high grade dysplasia in ulcerative colitis using systemic or local
5-aminolaevulinic acid sensitisation. Gut 2003;52:1003–7.
30. Ochsenkuhn T, Tillack C, Stepp H, et al. Low frequency of colorectal dysplasia in
patients with long-standing inflammatory bowel disease colitis: detection by
fluorescence endoscopy. Endoscopy 2006;38:477–82.
31. Kara MA, Bergman JJ. Autofluorescence imaging and narrow-band imaging for the
detection of early neoplasia in patients with Barrett’s esophagus. Endoscopy
2006;38:627–31.
32. Curvers WL, Singh R, Song LM, et al. Endoscopic tri-modal imaging for detection of
early neoplasia in Barrett’s oesophagus: a multi-centre feasibility study using high-
resolution endoscopy, autofluorescence imaging and narrow band imaging
incorporated in one endoscopy system. Gut 2008;57:167–72.
33. Matsumoto T, Moriyama T, Yao T, et al. Autofluorescence imaging colonoscopy for
the diagnosis of dysplasia in ulcerative colitis. Inflamm Bowel Dis 2007;13:640–1.
34. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis
refractory to steroid therapy. N Engl J Med 1994;330:1841–5.
35. Endoscopic Classification Review Group. Update on the paris classification of
superficial neoplastic lesions in the digestive tract. Endoscopy 2005;37:570–8.
36. Kudo S, Rubio CA, Teixeira CR, et al. Pit pattern in colorectal neoplasia: endoscopic
magnifying view. Endoscopy 2001;33:367–73.
37. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal
epithelial neoplasia. Gut 2000;47:251–5.
38. Kilgore SP, Sigel JE, Goldblum JR. Hyperplastic-like mucosal change in Crohn’s
disease: an unusual form of dysplasia? Mod Pathol 2000;13:797–801.
39. Brand S, Stepp H, Ochsenkuhn T, et al. Detection of colonic dysplasia by light-
induced fluorescence endoscopy: a pilot study. Int J Colorectal Dis 1999;14:63–8.
40. Haringsma J, Tytgat GN, Yano H, et al. Autofluorescence endoscopy: feasibility of
detection of GI neoplasms unapparent to white light endoscopy with an evolving
technology. Gastrointest Endosc 2001;53:642–50.
41. Kara MA, Peters FP, ten Kate FJ, et al. Endoscopic video autofluorescence imaging
may improve the detection of early neoplasia in patients with Barrett’s esophagus.
Gastrointest Endosc 2005;61:679–85.
42. Matsumoto T, Kudo T, Yao T, et al. Autofluorescence imaging colonoscopy in
ulcerative colitis: Comparison with conventional and narrow-band imaging
colonoscopy. Dig Endosc 2007;19(Suppl 1):S139–S144.
43. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel
disease: standardized classification with provisional clinical applications. Hum Pathol
1983;14:931–68.
44. Rubin DT, Turner JR. Surveillance of dysplasia in inflammatory bowel disease: The
gastroenterologist–pathologist partnership. Clin Gastroenterol Hepatol
2006;4:1309–13.
45. Bernstein CN. ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy?
Gastroenterology 1999;117:1488–92.
46. Hurlstone DP, Sanders DS, Atkinson R, et al. Endoscopic mucosal resection for flat
neoplasia in chronic ulcerative colitis: can we change the endoscopic management
paradigm? Gut 2007;56:838–46.
47. Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is
visible at colonoscopy. Gastrointest Endosc 2004;60:334–9.
48. Kara MA, Peters FP, Fockens P, et al. Endoscopic video-autofluorescence imaging
followed by narrow band imaging for detecting early neoplasia in Barrett’s esophagus.
Gastrointest Endosc 2006;64:176–85.
49. Hurlstone DP, Kiesslich R, Thomson M, et al. Confocal chromoscopic
endomicroscopy is superior to chromoscopy alone for the detection and
characterisation of intraepithelial neoplasia in chronic ulcerative colitis. Gut
2008;57:196–204.
ANSWER
From the question on page 1048
The computed tomography (CT) scan of the abdomen, thorax and extremities demonstrated
extensive retroperitoneal gas, adjacent to the sigmoid colon, with extension into the neck,
mediastinum, preperitoneum, left leg and scrotum. This patient was diagnosed with a
retroperitoneal and thigh abscess due to perforated diverticulitis. Segmental colic resection with
an end colostomy was performed. Faecal material was drained from the retroperitoneum and
thigh. Histopathological examination of the specimen demonstrated perforated diverticulitis.
After 7 weeks in the intensive care unit the patient was discharged. Unfortunately, the patient
died unexpectedly after 9 days. An autopsy was not performed.
Soft tissue abscesses of the groin, thigh, hip and buttock may be extra-abdominal
manifestations of perforated diverticulitis or other intra-abdominal pathology. This rare
presentation occurs more often in elderly patients.
1 A review of 46 reported cases of thigh
abscesses noted that the main underlying diseases were perforations from diverticulitis or
colorectal cancer. The overall mortality is high and therefore awareness and recognition of an
intra-abdominal source for ‘‘cellulitis’’ in the thigh or groin is important.
2
Gut 2008;57:1089. doi:10.1136/gut.2007.141853a
REFERENCES
1. Rothenbuehler JM, Oertli D, Harder F. Extraperitoneal manifestation of perforated diverticulitis. Dig Dis Sci 1993;38:1985–8.
2. Rotstein OD, Pruett TL, Simmons RL. Thigh abscess, an uncommon presentation of intraabdominal sepsis [abstract]. Am J Surg
1986;151:414–8.
Editor’s quiz: GI snapshot
Ulcerative colitis
Gut August 2008 Vol 57 No 8 1089